Evaluation of our first–year endoscopic retrograde cholangiopancreatography results
Ufuk Arslan, Hacı Murat Çaycı, Ali Tardu, Umut Eren ErdoğduDepartment of General Surgery, Health Sciences University, Bursa Yüksek İhtisas Training and Research Hospital, Bursa, TurkeyINTRODUCTION: In this study, the results of the first year of endoscopic retrograde cholangiopancreatography (ERCP), which has been started to be performed in our center, have been evaluated.
METHODS: A retrospective analysis was carried out with data of 345 patients who underwent ERCP performed by the same team at a single center between April 2019 and April 2020. The patients were assessed for demographic data, indications for the procedure, procedure–related complications, endoscopic findings and interventions.
RESULTS: A total of 345 patients underwent the procedure, with a total of 412 procedures were performed. The patient group comprised 210 women and 135 men, with a mean age of 56.4 (19–86) years. The mean duration of the procedure was 12 (4–48) minutes. The most common (60.4%) indications for ERCP were radiologically detected ductus choledochus stones and elevated liver enzymes and/or hyperbilirubinemia. Successful cannulation was performed using a standard sphincterotome in a total of 370 procedures. The number of procedures performed using a precut needle–knife sphincterotome was 28; however, cannulation was successful only in 16. The total cannulation rate was 93.6%. The most common complication (2.9%) was post–ERCP pancreatitis and 30 (7.2%) patients developed post–ERCP complications.
DISCUSSION AND CONCLUSION: Endoscopic retrograde cholangiopancreatography is an endoscopic method commonly used for the treatment of pancreaticobiliary diseases. We believe that it should be applied as a therapeutic procedure rather than as a diagnostic tool, being an invasive procedure.
Manuscript Language: English